Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Prostaglandins and Other Lipid Mediators | journal | 1.302 Q1 | 86 | 41 | 187 | 2066 | 497 | 183 | 2.81 | 50.39 | |
52 | Current Topics in Medicinal Chemistry | journal | 1.276 Q1 | 133 | 101 | 122 | 9968 | 531 | 122 | 4.35 | 98.69 | |
53 | Current Drug Targets | journal | 1.255 Q1 | 119 | 62 | 90 | 6207 | 306 | 83 | 3.09 | 100.11 | |
54 | Journal of Gene Medicine | journal | 1.238 Q1 | 100 | 110 | 185 | 4356 | 745 | 181 | 3.77 | 39.60 | |
55 | Alcoholism: Clinical and Experimental Research | journal | 1.200 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
56 | Pharmaceutical Research | journal | 1.170 Q1 | 229 | 275 | 762 | 7452 | 2232 | 752 | 2.70 | 27.10 | |
57 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 82 | 13 | 45 | 1928 | 159 | 44 | 3.52 | 148.31 | |
58 | Toxicology and Applied Pharmacology | journal | 1.144 Q1 | 189 | 207 | 638 | 9431 | 2069 | 623 | 3.10 | 45.56 | |
59 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.141 Q1 | 185 | 109 | 246 | 2583 | 607 | 245 | 1.76 | 23.70 | |
60 | International Journal of Neuropsychopharmacology | journal | 1.127 Q1 | 125 | 58 | 144 | 2265 | 423 | 133 | 3.00 | 39.05 | |
61 | Journal of Natural Products | journal | 1.123 Q1 | 161 | 370 | 1258 | 7497 | 2669 | 1254 | 2.08 | 20.26 | |
62 | Toxicological Sciences | journal | 1.116 Q1 | 207 | 277 | 802 | 11064 | 2556 | 775 | 2.97 | 39.94 | |
63 | Journal of Immunotherapy | journal | 1.112 Q1 | 106 | 39 | 119 | 1227 | 410 | 106 | 4.20 | 31.46 | |
64 | Advances in Pharmacology | journal | 1.111 Q1 | 86 | 0 | 29 | 0 | 84 | 27 | 0.00 | 0.00 | |
65 | Clinical Pharmacology and Therapeutics | journal | 1.104 Q1 | 209 | 140 | 807 | 3952 | 2466 | 744 | 2.42 | 28.23 | |
66 | Current Gene Therapy | journal | 1.104 Q1 | 80 | 40 | 58 | 4126 | 234 | 58 | 4.03 | 103.15 | |
67 | Current Cancer Drug Targets | journal | 1.097 Q1 | 103 | 39 | 36 | 3957 | 140 | 36 | 3.89 | 101.46 | |
68 | Behavioural Pharmacology | journal | 1.090 Q1 | 87 | 71 | 202 | 3022 | 459 | 189 | 1.99 | 42.56 | |
69 | Journal of Analytical Toxicology | journal | 1.090 Q1 | 85 | 100 | 341 | 1905 | 668 | 318 | 1.84 | 19.05 | |
70 | Clinical Therapeutics | journal | 1.080 Q1 | 150 | 219 | 496 | 8226 | 1668 | 408 | 2.95 | 37.56 | |
71 | Pharmacology Biochemistry and Behavior | journal | 1.072 Q1 | 148 | 259 | 913 | 11935 | 2198 | 907 | 2.43 | 46.08 | |
72 | Nucleic Acid Therapeutics | journal | 1.070 Q1 | 77 | 52 | 131 | 2046 | 363 | 125 | 2.65 | 39.35 | |
73 | Critical Reviews in Toxicology | journal | 1.068 Q1 | 129 | 20 | 64 | 2954 | 239 | 64 | 2.54 | 147.70 | |
74 | Addictive Behaviors | journal | 1.062 Q1 | 149 | 138 | 252 | 4316 | 511 | 251 | 1.90 | 31.28 | |
75 | Helvetica Chimica Acta | journal | 1.050 Q1 | 87 | 335 | 879 | 11462 | 1723 | 877 | 1.95 | 34.21 | |
76 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.029 Q1 | 106 | 44 | 172 | 1601 | 324 | 172 | 1.29 | 36.39 | |
77 | Current Opinion in Molecular Therapeutics | journal | 1.024 Q1 | 67 | 101 | 252 | 4049 | 725 | 232 | 2.95 | 40.09 | |
78 | Journal of Psychopharmacology | journal | 1.017 Q1 | 135 | 74 | 186 | 2578 | 491 | 173 | 2.11 | 34.84 | |
79 | Journal of Pharmaceutical Sciences | journal | 1.007 Q1 | 206 | 245 | 629 | 8003 | 1558 | 624 | 2.34 | 32.67 | |
80 | PharmacoEconomics | journal | 1.006 Q1 | 118 | 103 | 328 | 4348 | 869 | 317 | 2.53 | 42.21 | |
81 | Antiviral Research | journal | 0.995 Q1 | 151 | 95 | 230 | 4546 | 757 | 230 | 3.36 | 47.85 | |
82 | Journal of Computer-Aided Molecular Design | journal | 0.990 Q1 | 119 | 63 | 231 | 2607 | 699 | 229 | 2.37 | 41.38 | |
83 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.984 Q1 | 99 | 156 | 479 | 5878 | 1208 | 477 | 2.01 | 37.68 | |
84 | Drug Safety | journal | 0.981 Q1 | 140 | 82 | 257 | 5422 | 1071 | 252 | 3.67 | 66.12 | |
85 | International Journal of Pharmaceutics | journal | 0.981 Q1 | 258 | 396 | 1211 | 9238 | 2442 | 1202 | 1.87 | 23.33 | |
86 | European Journal of Pharmaceutical Sciences | journal | 0.979 Q1 | 163 | 133 | 411 | 3924 | 1134 | 391 | 2.32 | 29.50 | |
87 | Drug Metabolism Reviews | journal | 0.975 Q1 | 108 | 20 | 77 | 1644 | 267 | 75 | 3.49 | 82.20 | |
88 | Experimental and Clinical Psychopharmacology | journal | 0.973 Q1 | 101 | 34 | 177 | 1404 | 305 | 176 | 1.39 | 41.29 | |
89 | European Journal of Pharmacology | journal | 0.971 Q1 | 203 | 759 | 2506 | 31129 | 6504 | 2501 | 2.49 | 41.01 | |
90 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | |
91 | Food Additives and Contaminants | journal | 0.946 Q1 | 121 | 151 | 404 | 3884 | 755 | 398 | 1.79 | 25.72 | |
92 | European Neuropsychopharmacology | journal | 0.926 Q1 | 130 | 88 | 229 | 3082 | 561 | 224 | 2.36 | 35.02 | |
93 | Ecotoxicology | journal | 0.921 Q1 | 107 | 49 | 118 | 2197 | 216 | 110 | 1.51 | 44.84 | |
94 | Pharmacogenomics | journal | 0.921 Q1 | 100 | 95 | 159 | 3303 | 452 | 145 | 2.48 | 34.77 | |
95 | Anti-Cancer Drug Design | journal | 0.917 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
96 | Investigational New Drugs | journal | 0.907 Q1 | 97 | 46 | 130 | 1813 | 337 | 127 | 2.37 | 39.41 | |
97 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.906 Q1 | 108 | 41 | 57 | 4139 | 140 | 55 | 2.46 | 100.95 | |
98 | Steroids | journal | 0.906 Q1 | 114 | 134 | 351 | 5085 | 975 | 348 | 2.46 | 37.95 | |
99 | Receptors and Channels | journal | 0.887 Q1 | 44 | 40 | 71 | 2478 | 131 | 67 | 2.00 | 61.95 | |
100 | Bioorganic and Medicinal Chemistry | journal | 0.883 Q1 | 187 | 536 | 1074 | 17122 | 2344 | 1073 | 2.26 | 31.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®